Ibuprofen reduces energy expenditure and acute-phase protein production compared with placebo in pancreatic cancer patients
Authors:
- Js FalconerJFJs Falconer
- Ce PlesterCPCe Plester
- Ja RossJRJa Ross
- Jp MaingayJMJp Maingay
- Dc CarterDCDc Carter
- Kch FearonKFKch Fearon
Open Access
- 1 July 1995
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 72 (1) , 185-188
Abstract
The aim of this study was to investigate the effect of the cyclo-oxygenase inhibitor ibuprofen on the acute-phase protein response and resting energy expenditure (REE) of weight-losing patients with pancreatic cancer. Patients with irresectable pancreatic cancer (n = 16) were treated with either ibuprofen (1200 mg day-1 for 7 days (n = 10) or placebo (n = 6). A group of 17 age-related non-cancer subjects were also studied. Indirect calorimetry, anthropometry, multifrequency bioelectrical impedence analysis and serum C-reactive protein (CRP) estimation were performed immediately before and after treatment. Before treatment, total REE was significantly elevated in the pancreatic cancer patients compared with healthy controls (1499 +/- 71 vs 1377 +/- 58 kcal) (P < 0.02). Following treatment the mean REE of the ibuprofen group fell significantly (1386 +/- 89 kcal) compared with pretreatment values (1468 +/- 99 kcal) (P < 0.02), whereas no change was observed in the placebo group. Serum CRP concentration was also reduced in the ibuprofen-treated group (pre-ibuprofen, 51 mg l-1; post-ibuprofen, 29 mg l-1; P < 0.05). These results suggest that ibuprofen may have a role in abrogating the catabolic processes which contribute to weight loss in patients with pancreatic cancer.Keywords
This publication has 19 references indexed in Scilit:
- Cytokines, the Acute-Phase Response, and Resting Energy Expenditure in Cachectic Patients with Pancreatic CancerAnnals of Surgery, 1994
- Suramin interferes with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental cancer cachexia in vivo.Journal of Clinical Investigation, 1993
- AUTOREGULATION OF HEPATIC MACROPHAGE ACTIVATION IN SEPSIS1993
- The mechanisms and treatment of weight loss in cancerProceedings of the Nutrition Society, 1992
- Ibuprofen Lowers Body Temperature and Metabolic Rate of Humans with Burn Injury1992
- Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents.Journal of Experimental Medicine, 1991
- Elevated Circulating Interleukin-6 Is Associated with an Acute-phase Response but Reduced Fixed Hepatic Protein Synthesis in Patients with CancerAnnals of Surgery, 1991
- Evaluation of metabolic measuring instruments for use in critically ill patientsCritical Care Medicine, 1990
- Correlation of serologic indicators of inflammation with effectiveness of nonsteroidal antiinflammatory drug therapy in rheumatoid arthritisArthritis & Rheumatism, 1990
- Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation.Journal of Experimental Medicine, 1988